While Medpace Holdings Inc has underperformed by -2.26%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, MEDP rose by 31.77%, with highs and lows ranging from $501.30 to $250.05, whereas the simple moving average jumped by 33.13% in the last 200 days.
On July 29, 2025, UBS Downgraded Medpace Holdings Inc (NASDAQ: MEDP) to Sell. A report published by TD Cowen on July 23, 2025, Downgraded its rating to ‘Sell’ for MEDP. Barclays also rated MEDP shares as ‘Equal Weight’, setting a target price of $300 on the company’s shares in an initiating report dated June 24, 2025. TD Cowen April 14, 2025d its ‘Buy’ rating to ‘Hold’ for MEDP, as published in its report on April 14, 2025. Leerink Partners’s report from March 24, 2025 suggests a price prediction of $330 for MEDP shares, giving the stock a ‘Market Perform’ rating. Robert W. Baird also rated the stock as ‘Neutral’.
Analysis of Medpace Holdings Inc (MEDP)
Further, the quarter-over-quarter increase in sales is 14.24%, showing a positive trend in the upcoming months.
Medpace Holdings Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of 89.38% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.43, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and MEDP has an average volume of 495.61K. On a monthly basis, the volatility of the stock is set at 4.16%, whereas on a weekly basis, it is put at 4.19%, with a gain of 0.08% over the past seven days. Furthermore, long-term investors anticipate a median target price of $418.40, showing decline from the present price of $437.78, which can serve as yet another indication of whether MEDP is worth investing in or should be passed over.
How Do You Analyze Medpace Holdings Inc Shares?
Diagnostics & Research giant Medpace Holdings Inc (MEDP) is based in the USA and is one of the largest companies in the market. When comparing Medpace Holdings Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 32.56, there is a growth in quarterly earnings of 12.47%.
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 19.40%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 92.78% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
MEDP shares are owned by institutional investors to the tune of 92.78% at present.
